LOGO
LOGO

Corporate News

Flotek Industries Q2 Profit Slips; Expects Higher Adj. EBITDA, Revenue In FY25

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

Flotek Industries (FTK), a green chemistry and technology data firm, on Wednesday reported lower earnings in its second quarter, mainly hurt by non-recurring fees and higher interest expense. However, Adjusted EBITDA and revenue improved.

For the second quarter, the firm reported a 10% decrease in net income to $1.77 million from $1.97 million in the prior year.

The earnings per share declined 17% to $0.05 from $0.06 a year ago.

Adjusted net income was $5.96 million, compared to $1.97 million in the prior year.

On a per share basis, adjusted net income was $0.16, compared to $0.06 a year ago.

Income before tax decreased to $1.79 million from $1.99 million a year ago.

Adjusted EBITDA improved 113% to $9.45 million from $4.44 million in the prior year.

Total revenues increased 26% to $58.35 million from $46.15 million in the last year.

Looking ahead for fiscal 2025, the company expects total revenue in the range of $200 million to $220 million, a 12% growth at the midpoint compared to last year.

Also, the company expects adjusted EBITDA in the range of $34 million to $39 million for the full year. At mid-point, the outlook represents an 80% improvement from last year, amounting to $36.5 million, which represents the highest in more than a decade.

In the after hours, FTK shares traded 1.50% higher at $12.21 on the NYSE.

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

Latest Updates on COVID-19